InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
InflaRx | 424B5: Prospectus
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 20-F: FY2023 Annual Report
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
InflaRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(3.2%),Tang Capital Management, LLC(3.2%), etc.
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
InflaRx | 6-K: Report of foreign private issuer (related to financial reporting)
No Data